Adults and adolescents were included in 3 phase 3 omalizumab trials in chronic idiopathic urticaria (CIU): ASTERIA I, ASTERIA II, and GLACIAL. http://ift.tt/2oLPrSQ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου